Raiffeisen Bank International AG lowered its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 5.4% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 22,925 shares of the medical instruments supplier’s stock after selling 1,313 shares during the period. Raiffeisen Bank International AG’s holdings in Mettler-Toledo International were worth $27,312,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also modified their holdings of the company. GAMMA Investing LLC boosted its stake in shares of Mettler-Toledo International by 1.6% in the third quarter. GAMMA Investing LLC now owns 510 shares of the medical instruments supplier’s stock worth $626,000 after buying an additional 8 shares during the last quarter. Versant Capital Management Inc lifted its holdings in Mettler-Toledo International by 42.1% in the third quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after acquiring an additional 8 shares during the period. Valeo Financial Advisors LLC lifted its holdings in Mettler-Toledo International by 4.0% in the third quarter. Valeo Financial Advisors LLC now owns 207 shares of the medical instruments supplier’s stock valued at $254,000 after acquiring an additional 8 shares during the period. Meridian Wealth Management LLC boosted its position in Mettler-Toledo International by 1.7% in the 3rd quarter. Meridian Wealth Management LLC now owns 480 shares of the medical instruments supplier’s stock worth $589,000 after purchasing an additional 8 shares in the last quarter. Finally, Greenleaf Trust grew its stake in shares of Mettler-Toledo International by 1.2% during the 3rd quarter. Greenleaf Trust now owns 784 shares of the medical instruments supplier’s stock worth $962,000 after purchasing an additional 9 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.
Insiders Place Their Bets
In other news, CFO Shawn Vadala sold 800 shares of Mettler-Toledo International stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the sale, the chief financial officer owned 5,288 shares in the company, valued at approximately $7,456,714.56. The trade was a 13.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider La Guerroniere Marc De sold 6,055 shares of the stock in a transaction that occurred on Tuesday, November 25th. The shares were sold at an average price of $1,488.18, for a total value of $9,010,929.90. Following the completion of the sale, the insider directly owned 187 shares of the company’s stock, valued at $278,289.66. The trade was a 97.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 8,880 shares of company stock valued at $13,138,326. 1.94% of the stock is owned by corporate insiders.
Mettler-Toledo International Stock Up 0.0%
Mettler-Toledo International (NYSE:MTD – Get Free Report) last posted its quarterly earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $12.76 by $0.60. The company had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.10 billion. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.Mettler-Toledo International’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter last year, the company earned $12.41 EPS. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. Analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.
Analysts Set New Price Targets
Several research firms recently issued reports on MTD. Citigroup boosted their target price on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Morgan Stanley dropped their price target on Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 10th. Weiss Ratings restated a “hold (c+)” rating on shares of Mettler-Toledo International in a report on Monday, December 29th. The Goldman Sachs Group initiated coverage on Mettler-Toledo International in a report on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective on the stock. Finally, Barclays cut their price objective on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating for the company in a research report on Monday, December 15th. Six equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $1,435.42.
Check Out Our Latest Research Report on Mettler-Toledo International
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Featured Stories
- Five stocks we like better than Mettler-Toledo International
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
